A Study of Anti-HIV Monoclonal Antibody KD-247

NCT00917813 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: KD-247
DRUG: Physiological saline

Sponsor

The Chemo-Sero-Therapeutic Research Institute